Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which combination chemotherapy regimen is most effective for transitional cell
cancer of the urothelium.
PURPOSE: Randomized phase II/III trial to compare different combination chemotherapy regimens
in treating patients who have transitional cell cancer of the urothelium.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC